CVRx, Inc. (CVRX) vs Werewolf Therapeutics, Inc. (HOWL)

A side-by-side comparison of CVRx, Inc. and Werewolf Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CVRX vs HOWL

growth of $100 · dividends reinvested · last 5y
CVRX -94.4% (-43.9%/yr)HOWL -94.7% (-44.4%/yr)CVRX compounded faster over this window
050100Start $10020222023202420252026$6$5
CVRX HOWL

CVRX vs HOWL: by the numbers

  • •HOWL is the larger company ($45M vs $44M market cap).
  • •Both run net losses; CVRX's is the smaller (-84.93% vs -164.82% net margin).

Metrics side by side

Valuation

MetricCVRXHOWL
P/S ratio0.722.15
P/B ratio2.222.77

Profitability

MetricCVRXHOWL
Gross margin86.60%0.00%
Operating margin-90.49%0.00%
Net margin-84.93%-164.82%
ROE-260.45%-212.45%
ROIC-59.93%-156.97%

Growth (annualized)

MetricCVRXHOWL
Revenue CAGR (5Y)46.51%N/A
Total return CAGR (5Y)-37.86%-44.27%

Frequently asked

How have CVRX and HOWL total returns compared?
Over the past 5 years, CVRX delivered -37.86% and HOWL delivered -44.27% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.